1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Technology Transfer (STTR) Grant, Phase I is sponsored by National Institute of Neurological Disorders and Stroke (NINDS). This program supports cooperative R&D projects between small business concerns and research institutions, limited in time and amount, to establish the technical merit and feasibility of ideas that have potential for commercialization.
Get alerted about grants like this
Get emailed when new opportunities from “National Institute of Neurological Disorders and Stroke (NINDS)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Business Technology Transfer (STTR) Grants - Phase I (R41) | Grants & Funding U.S. Department of Health and Human Services National Institutes of Health Small Business Technology Transfer (STTR) Grants - Phase I (R41) To help small businesses that partner with a nonprofit research institution bring scientific innovations to the marketplace.
The STTR supports research and development (R&D) awards to eligible United States small business concerns only. Note: General Small Business Information Visit Small Business for general guidance, policy, and program information. Find ICO Specific Information Funding Considerations and The focus of a Phase 1 award is on the feasibility, technical merit, and commercial potential of the research project.
Carefully read the Eligibility section of the funding opportunity for opportunity-specific organization eligibility requirements. Project Director/ Principal Investigator (PD/PI) Eligibility PD/PI must be employed by either the partnering research institution or small business. Carefully read the Eligibility section of the funding opportunity for opportunity-specific PD/PI eligibility requirements.
Standard Due Dates apply. Standard Application Due Dates (when applicable) Participating Funding Organizations Each funding opportunity specifies the participating organizations. Applications must fit within the mission of at least one participating funding organization and meet all opportunity-specific requirements.
The following funding organizations participate on at least one active funding opportunity.
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Eunice Kennedy Shriver National Institute of Child Health and Human Development National Cancer Institute National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Heart, Lung, and Blood Institute National Human Genome Research Institute National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute on Deafness and Other Communication Disorders National Institute on Drug Abuse National Institute on Minority Health and Health Disparities National Library of Medicine Office of Research on Women's Health NIH SEED: Understanding SBIR and STTR website NIH Grants Policy Statement Section 18.
5 Small Business Innovation Research and Small Business Technology Transfer Programs For technical issues E-mail OER Webmaster
According to the current listing, eligibility includes: Small business concerns (SBCs) in partnership with a non-profit research institution. The Principal Investigator must be employed by either the partnering research institution or the small business (minimum 10% effort). Confirm the full requirements in the official notice before applying.
Applications for Small Business Technology Transfer (STTR) Grant, Phase I are due September 5, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Small Business Technology Transfer (STTR) Grant, Phase I is funded by National Institute of Neurological Disorders and Stroke (NINDS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The AIR program is ARPA-H's most ambitious bet yet: fully autonomous robots that perform stroke-saving thrombectomies without a human surgeon. Proposals are due March 18. A strategic guide for applicants.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read article